PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
-20.47%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.84B
AUM Growth
-$1.16B
Cap. Flow
-$25.7M
Cap. Flow %
-0.67%
Top 10 Hldgs %
54.94%
Holding
138
New
22
Increased
22
Reduced
18
Closed
23

Top Buys

1
IOVA icon
Iovance Biotherapeutics
IOVA
$67.5M
2
ZYME icon
Zymeworks
ZYME
$41M
3
REGN icon
Regeneron Pharmaceuticals
REGN
$39.1M
4
NVRO
NEVRO CORP.
NVRO
$32.3M
5
BDTX icon
Black Diamond Therapeutics
BDTX
$27.6M

Top Sells

1
AMRN
Amarin Corp
AMRN
$152M
2
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
$80.7M
3
NBIX icon
Neurocrine Biosciences
NBIX
$47.5M
4
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$37.3M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
$22.7M

Sector Composition

1 Healthcare 95.71%
2 Technology 0.27%
3 Consumer Discretionary 0.02%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MTEM
26
DELISTED
Molecular Templates, Inc.
MTEM
$32.9M 0.86%
164,942
– –
ALBO
27
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$31.9M 0.83%
1,960,139
+255,809
+15% +$4.17M
AGIO icon
28
Agios Pharmaceuticals
AGIO
$2.36B
$31.9M 0.83%
900,000
– –
VAPO
29
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$31.4M 0.82%
208,758
-9,213
-4% -$1.39M
RCKT icon
30
Rocket Pharmaceuticals
RCKT
$358M
$30.5M 0.8%
2,189,010
-50,231
-2% -$701K
ALLO icon
31
Allogene Therapeutics
ALLO
$249M
$30M 0.78%
1,543,790
– –
AGRX
32
DELISTED
Agile Therapeutics, Inc
AGRX
$29.6M 0.77%
7,960
+2,000
+34% +$7.44M
DBVT
33
DBV Technologies
DBVT
$249M
$28.7M 0.75%
731,781
+295,000
+68% +$11.6M
ARNA
34
DELISTED
Arena Pharmaceuticals Inc
ARNA
$28.4M 0.74%
675,129
-278,000
-29% -$11.7M
PRVB
35
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$27.7M 0.72%
3,011,574
+90,000
+3% +$828K
BDTX icon
36
Black Diamond Therapeutics
BDTX
$164M
$27.6M 0.72%
+1,104,656
New +$27.6M
COLL icon
37
Collegium Pharmaceutical
COLL
$1.25B
$25.3M 0.66%
1,551,722
+1,130,450
+268% +$18.5M
CTMX icon
38
CytomX Therapeutics
CTMX
$350M
$25M 0.65%
3,253,923
– –
TBPH icon
39
Theravance Biopharma
TBPH
$692M
$23.1M 0.6%
+1,000,000
New +$23.1M
UROV
40
DELISTED
Urovant Sciences Ltd.
UROV
$21.8M 0.57%
2,366,831
-40,100
-2% -$370K
CNCE
41
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$19.5M 0.51%
2,150,641
– –
VYNE icon
42
VYNE Therapeutics
VYNE
$8.09M
$17.5M 0.45%
+92,183
New +$17.5M
RGNX icon
43
Regenxbio
RGNX
$498M
$17.1M 0.45%
508,000
-100,000
-16% -$3.38M
NEPT
44
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$15.7M 0.41%
9,598
– –
TPTX
45
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$15.4M 0.4%
349,890
-87,500
-20% -$3.86M
STOK icon
46
Stoke Therapeutics
STOK
$1.08B
$15.4M 0.4%
671,978
– –
DNLI icon
47
Denali Therapeutics
DNLI
$2.24B
$14.9M 0.39%
+850,000
New +$14.9M
TXG icon
48
10x Genomics
TXG
$1.66B
$13.8M 0.36%
220,000
– –
PODD icon
49
Insulet
PODD
$24.2B
$13.7M 0.36%
+82,733
New +$13.7M
RVNC
50
DELISTED
Revance Therapeutics, Inc.
RVNC
$13.7M 0.36%
925,000
+104,623
+13% +$1.55M
1
2
3 4 5